Viemed Healthcare Inc
Research Viemed Healthcare Inc (VMD) on Bullrun: valuation model: 14.4% undervalued, market cap USD 346.60M, P/E 24.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal14.4% undervalued
- Market capUSD 346.60M
- P/E24.9
- Financial periodQ2 2026
- RevenueUSD 78.10M
- Net incomeUSD 2.76M
- Free cash flowUSD 7.44M
- Gross margin57.7%
Valuation Snapshot
Bullrun's latest valuation model marks Viemed Healthcare Inc as 14.4% undervalued; latest market cap is USD 346.60M; P/E is 24.9.
Peer valuation comparison
Latest P/E is 24.86x versus a Healthcare sector median of 24.46x.
Latest P/E is 24.86x versus a United States median of 24.87x.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 270.28M | USD 15.40M | USD 11.93M | 57.5% | 0.37 | USD 13.50M | USD 12.38M | USD 141.55M |
| FY2024 | USD 224.26M | USD 11.40M | USD 1.32M | 59.4% | 0.28 | USD 17.54M | USD 4.00M | USD 131.39M |
| FY2023 | USD 183.01M | USD 10.20M | USD 19.12M | 61.6% | 0.25 | USD 12.84M | USD 7.07M | USD 113.90M |
| FY2022 | USD 138.83M | USD 6.20M | USD 4.85M | 61.0% | 0.16 | USD 16.91M | USD 0 | USD 97.09M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 346.60M | 24.9 | n/a | n/a |
| 2025 | 2025-12-31 | USD 282.48M | 20.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 313.85M | 29.7 | n/a | n/a |
| 2023 | 2023-12-29 | USD 302.14M | 34.1 | n/a | n/a |
| 2022 | 2022-12-30 | USD 287.43M | 37.8 | n/a | n/a |
| 2021 | 2021-12-31 | USD 206.92M | 23.7 | n/a | n/a |
About Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Viemed Healthcare Inc overvalued or undervalued?
Bullrun's valuation model currently marks Viemed Healthcare Inc as 14.4% undervalued.
What is Viemed Healthcare Inc's market cap?
Viemed Healthcare Inc's market capitalization is USD 346.60M.
What is Viemed Healthcare Inc's P/E ratio?
Viemed Healthcare Inc's price-to-earnings (P/E) ratio is 24.9.
What does Viemed Healthcare Inc do?
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.